Genomic regions of coxsackievirus B3 associated with cardiovirulence

Journal of Medical Virology

Volumn 52, Issue 3, 1997, Pages 341-347

  Lee, Cheol ^a   Maull, Elizabeth ^b   Chapman, Nora ^c   Tracy, Steve ^c   Gauntt, Charles ^d,e  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b AIR FORCE RESEARCH LABORATORY   (United States)

^c UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^d Mays Cancer Center at UT Health San Antonio   (United States)

^e UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

Chimeric viruses; Coxsackieviruses group B; Mice; Myocarditis; Recombinant viruses

Indexed keywords

CAPSID PROTEIN; COMPLEMENTARY DNA;

ADOLESCENT; AMINO ACID SEQUENCE; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COXSACKIE VIRUS B; GENE MAPPING; HUMAN; HUMAN CELL; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; VIRUS GENOME; VIRUS MYOCARDITIS; VIRUS RECOMBINANT; VIRUS VIRULENCE;

ANIMALS; BINDING SITES; COXSACKIEVIRUS INFECTIONS; ENTEROVIRUS B, HUMAN; GENOME, VIRAL; HELA CELLS; HUMANS; MALE; MICE; MYOCARDITIS; VIRULENCE;

ANIMALIA; COXSACKIEVIRUS; HUMAN ENTEROVIRUS B; MIRIDAE; MURINAE; NEPTUNIA;

EID: 0030741434     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9071(199707)52:3<341::AID-JMV18>3.0.CO;2-L     Document Type: Article

References (45)

1. Almond JW (1987): The attenuation of poliovirus neurovirulence. Annual Reviews of Microbiology 41:153-180.
2. Beck MA, Kolbeck PC, Rohr LH, Shi Q, Morris VC, Levander OA (1994): Increased virulence of a human enterovirus (coxsackievirus B3) in selenium-deficient mice. Journal of Infectious Diseases 170:351-357.
3. Beatrice ST, Katze MG, Zajac BA, Crowell RL (1980): Induction of neutralizing antibodies by the coxsackievirus B3 virion polypeptide, VP2. Virology 104:426-428.
4. Caggana M, Chan P, Ramsingh A (1993): Identification of a single amino acid residue in the capsid protein VP1 of coxsackievirus B4 that determines the virulent phenotype. Journal of Virology 67: 4797-4803.
5. Chapman NM, Ramsingh A, Tracy S (1997): Genetics of CVB virulence. In Tracy S, Chapman N, Mahy B (eds.): "The Coxsackie B Viruses." Heidelberg: Springer-Verlag (in press).
6. Chapman NM, Tracy S, Gauntt CJ, Fortmueller U (1990): Molecular detection and identification of enteroviruses using enzymatic amplification and nucleic acid hybridization. Journal of Clinical Microbiology 28:843-850.
7. Chapman NM, Tu Z, Tracy S, Gauntt CJ (1994): An infectious cDNA copy of the genome of a non-cardiovirulent coxsackievirus B3 strain: Its complete sequence analysis and comparison to the genomes of cardiovirulent coxsackieviruses. Archives of Virology 135:115-130.
8. Evans DMA, Dunn G, Minor PD, Schild GC, Cann AJ, Stanway G, Almond JW, Currey K, Maizel JV (1985): Increased neurovirulence associated with a single nucleotide change in a non-coding region of the Sabin type 3 poliovaccine genome. Nature 314:548-550.
9. Gauntt CJ, Trousdale MD, LaBadie DRL, Paque RE and Nealon T (1979): Properties of coxsackievirus B3 variants which are amyocarditic or myocarditic for mice. Journal of Medical Virology 3: 207-220.
10. Gauntt CJ, Pallansch MA (1996): Coxsackievirus B3 clinical isolates and murine myocarditis. Virus Research 41:89-99.
11. Gauntt CJ, Higdon A, Bowers D, Maull E, Wood J, Crawley R (1993): What lessons can be learned from animal model studies in viral heart disease? Scandinavian Journal of Infectious Diseases 88 (Suppl):49-65.
12. Grist NR, Reid D (1988): General pathogenicity and epidemiology. In Bendinelli M, Friedman H. (eds): "Coxsackieviruses - A General Update." New York: Plenum Press, pp 221-239.
13. Haller AA, Semler BL (1995): Stem-loop structure synergy in binding cellular proteins to the 5′ non-coding region of poliovirus RNA. Virology 206:923-934.
14. Hogle JM, Chow M, Filman DJ (1985): Three-dimensional structure of poliovirus at 2.9Å resolution. Science 229:1358-1365.
15. Huber SA, Job LP (1983): Differences in cytolytic T cell response of BALB/c mice infected with myocarditic and non-myocarditic strains of coxsackievirus group B, Type 3. Infection and Immunity 39:1419-1427.
16. Jackson RJ, Kaminski A (1995): Internal initiation of translation in eukaryotes: The picornavirus paradigm and beyond. RNA 1:985-1000.
17. Klump WM, Bergmann I, Muller BC, Amies D, Kandolf R (1990): Complete nucleotide sequence of infectious coxsackievirus B3 cDNA: Two initial 5′ uridine residues are regained during plus-stranded RNA synthesis. Journal of Virology 64:1573-1583.
18. Knowlton KU, Jeon E-S, Berkley N, Wessely R, Huber S (1996): A mutation in the puff region of VP2 attenuates the myocarditis phenotype of an infectious cDNA of the woodruff variant of coxsackievirus B3. Journal of Virology 70:7811-7818.
19. Le SY, Zuker M (1990): Common Structures of the 5′ non-coding RNA in enteroviruses and rhinoviruses. Thermodynamical stability and statistical significance. Journal of Molecular Biology 216:729-741.
20. Lerner AM, Wilson FM, Reyes MP (1975): Enteroviruses and the heart [with special emphasis on the probable role of coxsackieviruses, group B, types 1-5]. Modern Concepts in Cardiovascular Disease 44:7-15.
21. Leslie K, Blay R, Haisch C, Lodge A, Weller A, Huber S (1989): Clinical and experimental aspects of viral myocarditis. Clinical Microbiology Reviews 2:191-203.
22. Macadam AJ, Pollard SR, Ferguson G, Dunn G, Skuce R, Almond JW, Minor PD (1991): The 5′ noncoding region of the type 2 poliovirus vaccine strain contains determinants of attenuation and temperature sensitivity. Virology 181:451-458.
23. Minor PD (1992): The molecular biology of poliovaccines. Journal of General Virology 73:3065-3077.
24. Minor PD, Dunn G, Evans DMA, Magrath DI, John A, Howlett, JP, Phillips A, Westrop G, Wareham K, Almond JW, Hogle JM (1989): The temperature sensitivity of the Sabin type 3 vaccine strain of poliovirus: Molecular and structural effects of a mutation in the capsid protein. Journal of General Virology 70:1117-1123.
25. Minor PD, Macadam AJ, Stone DM, Almond JW (1993): Genetic basis of attenuation of the Sabin oral poliovirus vaccines. Biologicals 21:357-363.
26. Muckelbauer JK, Kremer M, Minor I, Diana G, Dutko FJ, Groarke J, Pevear DC, Rossman MG (1995): The structure of coxsackievirus B3 at 3.5Å resolution. Structure 3:653-667.
27. Palmenberg AC (1989): Sequence alignments of picornaviral capsid proteins. In Semler BL, Ehrenfeld E (eds.): "Molecular Aspects of Picornavirus Infection and Detection." Washington, D.C.: American Society for Microbiology, pp 211-241.
28. Racaniello VR (1988): Poliovirus neurovirulence. Advances in Virus Research 34:217-246.
29. Ramsingh AI, Collins DN (1995): A point mutation in the VP4 coding sequence of coxsackievirus B4 influences virulence. Journal of Virology 69:7278-7281.
30. Ren RB, Moss EG, Racaniello VR (1991): Identification of two determinants that attenuate vaccine-related type 2 poliovirus. Journal of Virology 65:1377-1380.
31. Rose NR, Neumann DA, Herskowitz A (1992): Coxsackievirus myocarditis. Advances in Internal Medicine 37:411-429.
32. Rossman NR, Arnold E, Erickson JW, Frankenberger EA, Griffith AG, Hecht HJ, Johnson JE, Kamer G, Lou M, Mosser AG, Rueckert RR, Sherry B, Vriend G (1985): Structure of a human common cold virus and functional relationship to other picornaviruses. Nature 317:145-153.
33. Sanger F, Nicklen S, Coulson AR (1977): DNA sequencing with chain terminating inhibitors. Proceedings of the National Academy of Sciences USA 74:5463-5467.
34. Skinner MA, Racaniello VR, Dunn G, Cooper J, Minor PD, Almond JW (1989): New model for the secondary structure of the 5′ non-coding RNA poliovirus is supported by biochemical and genetic data that also show that RNA secondary structure is important in neurovirulence. Journal of Molecular Biology 207:379-392.
35. 472 → U. Virology 17:5103-5109.
36. Tracy S (1988): The genome of the group B coxsackieviruses. In Bendinelli M, Herman F (eds.): "Coxsackievirus - A General Update." New York: Plenum Press pp 19-33.
37. Tracy S, Chapman NM, Beck MA (1991): Molecular biology and pathogenesis of coxsackie B viruses. Reviews in Medical Virology 1:145-154.
38. Tracy S, Chapman NM, Tu Z (1992): Coxsackievirus B3 from an infectious cDNA copy of the genome is cardiovirulent in mice. Archives of Virology 122:399-409.
39. Tracy S, Chapman NM, Romero J, Ramsingh A (1996): Genetics of coxsackievirus B cardiovirulence and inflammatory heart muscle disease. Trends in Microbiology 4:175-179.
40. Tracy SM, Gauntt CJ (1987): Phenotypic and genotypic differences among naturally occurring coxsackievirus B3 variants. European Heart Journal 8 (Suppl J):445-448.
41. Tu Z, Chapman NM, Hufnagel G, Tracy S, Romero JR, Barry WH, Zhao L, Currey K, Shapiro B (1995): The cardiovirulent phenotype of coxsackievirus B3 is determined at a single site in the genomic 5′ NTR non-translated region. Journal of Virology 69:4607-4618.
42. Van Houten N, Bouchard PE, Moraska A, Huber S (1991): Selection of an attenuated coxsackievirus B3 variant, using a monoclonal antibody reactive myocyte antigen. Journal of Virology 65:1286-1290.
43. Westrop GD, Wareham KA, Evans DMA, Dunn G, Minor PD, Magrath DI, Taffs F, Marsden S, Skinner MA, Schild GC, Almond JW (1989): Genetic basis of attenuation of the Sabin type 3 oral poliovirus vaccine. Journal of Virology 63:1338-1344.
44. Wimmer E, Hellen CVT, Cao X (1993): Genetics of poliovirus. Annual Review of Genetics 27:353-436.
45. Zhang HY, Yousef GE, Cunningham L, Blake NW, Yang XO, Bayston TA, Kandolf R, Archard LC (1993): Attenuation of a reactivated cardiovirulent coxsackievirus B3: The 5′-nontranslated region does not contain major attenuation determinants. Journal of Medical Virology 41:129-137.